New Zealand markets close in 5 hours 44 minutes

ALX Oncology Holdings Inc. (ALXO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
16.94-0.08 (-0.47%)
At close: 04:00PM EDT
16.94 0.00 (0.00%)
After hours: 04:01PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-160,805
-160,805
-123,482
-83,463
-45,740
Depreciation & amortisation
836
836
342
51
202
Stock-based compensation
26,273
26,273
23,839
13,914
5,436
Change in working capital
8,297
8,297
9,850
-4,027
247
Accounts payable
-649
-649
4,526
4,709
-3,744
Other working capital
-131,638
-131,638
-90,650
-73,024
-38,320
Other non-cash items
1,522
1,522
1,168
5,424
295
Net cash provided by operating activities
-130,364
-130,364
-89,223
-68,101
-38,289
Cash flows from investing activities
Investments in property, plant and equipment
-1,274
-1,274
-1,427
-4,923
-31
Purchases of investments
-246,629
-246,629
-376,789
0
0
Sales/maturities of investments
292,560
292,560
142,800
0
0
Other investing activities
-
-
-
-
641
Net cash used for investing activities
44,657
44,657
-235,416
-4,923
610
Cash flows from financing activities
Debt repayment
-388
-388
-388
-281
0
Common stock issued
58,887
58,887
0
0
368,256
Common stock repurchased
-
-
-
-
0
Other financing activities
-
-
-655
-
-10,354
Net cash used provided by (used for) financing activities
59,291
59,291
9,860
2,472
462,881
Net change in cash
32,875
32,875
-304,919
-68,080
888,083
Cash at beginning of period
48,888
48,888
363,667
434,219
9,017
Cash at end of period
22,472
22,472
48,888
363,667
434,219
Free cash flow
Operating cash flow
-130,364
-130,364
-89,223
-68,101
-38,289
Capital expenditure
-1,274
-1,274
-1,427
-4,923
-31
Free cash flow
-131,638
-131,638
-90,650
-73,024
-38,320